Skip to content

The study of the relationship between serum CTRP1 and type 2 diabetic retinopathy

The study of the relationship between serum CTRP1 and type 2 diabetic retinopathy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024516
Enrollment
Unknown
Registered
2019-07-13
Start date
2019-07-10
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy

Interventions

1. Type 2 diabetes mellitus without retinopathy
2. Type 2 diabetes mellitus with non-proliferative retinopathy
3. Type 2 diabetes mellitus with proliferative retinopathy
4. Healthy control group.:N/A

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: According to the diagnostic criteria of diabetes mellitus and diabetic retinopathy, aged 20 to 80 years.

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes mellitus and other types of diabetes mellitus; 2. Acute complications of diabetes such as ketoacidosis and hyperosmotic coma; 3. Glaucoma, macular edema and other eye diseases; 4. Received anti-angiogenesis drugs such as bevacizumab and lanimazumab; 5. Accept lipid-lowering drugs such as statins and beta, and antiplatelet drugs such as aspirin; 6. Systemic infection after severe trauma; 7. connective tissue disease; 8. Autoimmune diseases; 9. Infectious diseases such as hepatitis A and hepatitis B; 10. Have a history of malignant tumors; 11. Serious history of cardiovascular and cerebrovascular diseases; 12. Severe hepatorenal insufficiency (ALT > 3 times the normal value, eGFR < 60 ml/min/1.73 m2).

Design outcomes

Primary

MeasureTime frame
Complement C1q Tumor Necrosis Factor Related Protein 1;

Countries

China

Contacts

Public ContactZhang Huijuan

The First Affiliated Hospital of Harbin Medical University

hydzhj@126.com+86 13946030114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026